Myasthenia Gravis Market Size, Share, Growth Report 2030

Myasthenia Gravis Market

Myasthenia Gravis Market by Diagnosis (Edrophonium Tests, Blood Tests, Pulmonary Function Tests, Electrodiagnostic, Imaging, and Others), by Treatment (Surgery, Medication, Plasmapheresis and Intravenous Immunoglobulin, Autologous Hematopoietic Stem Cell Transplantation (HSCT), and others), and by End-User (Hospitals, Academic Research Institutes, Clinics, and Others): Global Industry Perspective, Comprehensive Analysis, and Forecast, 2018–2025

Category: Healthcare Report Format : PDF Pages: 110 Report Code: ZMR-3927 Published Date: Mar-2019 Status : Published

Global myasthenia gravis market expected to generate around USD 2,091 million by 2025, at a CAGR of around 10.2% between 2019 and 2025. Myasthenia Gravis is an autoimmune neuromuscular disorder that leads to serious muscle weakness. It is caused due to an error in the transmission of nerve impulses to muscles.

The report covers a forecast and an analysis of the myasthenia gravis market on a global and regional level. The study provides historical data for 2016, 2017, and 2018 along with a forecast from 2019 to 2025 based on revenue (USD Million). The study includes drivers and restraints of the myasthenia gravis market along with the impact they have on the demand over the forecast period. Additionally, the report includes the study of opportunities available in the myasthenia gravis market on a global level.

In order to give the users of this report a comprehensive view of the myasthenia gravis market, we have included a competitive landscape and an analysis of Porter’s Five Forces model for the market. The study encompasses a market attractiveness analysis, wherein all the segments are benchmarked based on their market size, growth rate, and general attractiveness.

Global Myasthenia Gravis MarketRequest Free Sample

The report provides company market share analysis to give a broader overview of the key players in the market. In addition, the report also covers key strategic developments of the market including acquisitions & mergers, new technology launch, agreements, partnerships, collaborations & joint ventures, R&D, and regional expansion of major participants involved in the market on a global and regional basis. Moreover, the study covers price trend analysis and product portfolio of various companies according to regions.

The study provides a decisive view of the myasthenia gravis market based on diagnosis, treatment, end-user, and region. All the segments have been analyzed based on present and future trends in the market are estimated from 2019 to 2025. By diagnosis, the market is segmented into edrophonium tests, blood tests, pulmonary function tests, electrodiagnostic, imaging, and others. By treatment, the market is segmented into surgery, medication, plasmapheresis and intravenous immunoglobulin, autologous hematopoietic stem cell transplantation (HSCT), and others. By end-user, the market is segmented into hospitals, academic research institutes, clinics, and others.

The regional segment includes the current and forecast demand for North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa with its further divided into major countries including the U.S., Canada, Germany, France, UK, Brazil, China, Japan, India, and Brazil.

Some key players of the global myasthenia gravis market are Novartis Pharmaceuticals Corporation, AbbVie Inc., Biogen Inc., Pfizer, Valeant Pharmaceuticals International, Bristol-Myers Squibb Company, F. Hoffmann Roche La Ltd., GlaxoSmithKline, RPG Life Sciences, and Grifols SA, among others.

This report segments the global myasthenia gravis market as follows:

Global Myasthenia Gravis Market: Diagnosis Analysis

  • Edrophonium Tests
  • Blood Tests
  • Pulmonary Function Tests
  • Electrodiagnostic
  • Imaging
  • Others

Global Myasthenia Gravis Market: Treatment Analysis

  • Surgery
  • Medication
  • Plasmapheresis and Intravenous Immunoglobulin
  • Autologous Hematopoietic Stem Cell Transplantation (HSCT)
  • Others

Global Myasthenia Gravis Market: End-User Analysis

  • Hospitals
  • Academic Research Institutes
  • Clinics
  • Other

Global Myasthenia Gravis Market: Regional Analysis

  • North America
    • The U.S.
  • Europe
    • UK
    • France
    • Germany
  • Asia Pacific
    • China
    • Japan
    • India
  • Latin America
    • Brazil
  • Middle East and Africa

Table Of Content


Free Analysis

Choose License Type

  • zion payment modes


Office Address

Contact Us

Zion Market Research
Tel: +1 (302) 444-0166
USA/Canada Toll Free No.+1 (855) 465-4651

Asia Pacific Office

3rd Floor, Mrunal Paradise, Opp Maharaja Hotel, Pimple Gurav, Pune 411061, Maharashtra, India
Phone No +91 7768 006 007, +91 7768 006 008

Contact #

US OFFICE NO +1 (302) 444-0166
US/CAN TOLL FREE +1 (855) 465-4651

We Are On Social

Industry Press Release

We Accept

We have secured system to process your transaction.

  • payment methods

Business Hours

Our support available to help you 24 hours a day, five days a week.

Monday - Friday: 9AM - 6PM

Saturday - Sunday: Closed